Article
Analysis of EGFR mutation status in malignant pleural effusion and plasma from patients with advanced lung adenocarcinoma.
Clinical chemistry and laboratory medicine - 27 Aug 2020
Son Seung-Myoung, Woo Chang Gok, Han Hye Sook, Lee Ki Hyeong, Lim Young Hyun, Lee Ok-Jun
Abstract excerpt
Background: Cell-free DNA (cfDNA) is emerging as a surrogate sample type for mutation analyses. We investigated the suitability of malignant pleural effusion (MPE) and plasma as a biomaterial for analyzing epidermal growth factor receptor (EGFR) mutation by peptide nucleic acid (PNA) clamping-assisted fluorescence melting curve (PANAMutyper™) analysis. Methods: Matched tissue, MPE cell block (MPE-CB), MPE...
Topics
- Adenocarcinoma of Lung
- Adult
- Aged
- Aged, 80 and over
- Biomarkers, Tumor
- Circulating Tumor DNA
- ErbB Receptors
- Female
- Humans
- Lung Neoplasms
- Male
